Amgad M Rabie

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 30

Top Topics

Coronavirus Disease

Molecular Docking

Top Venues

Scientific reports

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

ChemistrySelect

This page only lists publications with an associated author ORCID identifier.

Publications

Amgad M Rabie
Revolutionizing Playing with Skeleton Atoms: Molecular Editing Surgery in Medicinal Chemistry. Mini reviews in medicinal chemistry (2024)
Mohd Adnan Kausar, Amgad M Rabie, Faizul Azam, Sadaf Anwar, Fahaad Alenazi, Khalid F Alshammari, Subhabrata Kar, Abrar Ali, Shimaa M H AboElnaga, Azfar Jamal, Gagandeep Singh, Lovnish Thakur, Mohammad Z Najm, Mohd Saeed
The role of Aedes aegypti in inducing/aggravating IgE-mediated allergic airway disease: extensive computational studies for identification of allergenic proteins. Journal of biomolecular structure & dynamics (2023)
Amgad M Rabie, Wafa Ali Eltayb
Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study. Molecular biotechnology (2023)
Amgad M Rabie, Marwa A Abdel-Dayem, Mohnad Abdalla
Promising Experimental Anti-SARS-CoV-2 Agent "SLL-0197800": The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus. ACS omega 8 (39) (2023)
Yasser Hussein Eissa Mohammed, Israa M Shamkh, Nahed S Alharthi, Mohammed A Shanawaz, Hind A Alzahrani, Basit Jabbar, Saba Beigh, Saad Alghamdi, Nada Alsakhen, Elshiekh B Khidir, Hayaa M Alhuthali, Taqwa Hafiz Elamin Karamalla, Amgad M Rabie
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Scientific reports 13 (1) (2023)
Yasser Hussein Eissa Mohammed, Israa M Shamkh, Nahed S Alharthi, Mohammed A Shanawaz, Hind A Alzahrani, Basit Jabbar, Saba Beigh, Saad Alghamdi, Nada Alsakhen, Elshiekh B Khidir, Hayaa M Alhuthali, Taqwa Hafiz Elamin Karamalla, Amgad M Rabie
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Scientific reports 13 (1) (2023)
Amgad M Rabie
RNA: The most attractive target in recent viral diseases. Chemical biology & drug design (2023)
Yasser Hussein Eissa Mohammed, Israa M Shamkh, Nahed S Alharthi, Mohammed A Shanawaz, Hind A Alzahrani, Basit Jabbar, Saba Beigh, Saad Alghamdi, Nada Alsakhen, Elshiekh B Khidir, Hayaa M Alhuthali, Taqwa Hafiz Elamin Karamalla, Amgad M Rabie
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Scientific reports 13 (1) (2023)
Nermin A Osman, Mohammed Moustapha Anwar, Bivek Singh, Girish K Gupta, Amgad M Rabie
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM). The Journal of the Egyptian Public Health Association 98 (1) (2023)
Yasser Hussein Eissa Mohammed, Israa M Shamkh, Nahed S Alharthi, Mohammed A Shanawaz, Hind A Alzahrani, Basit Jabbar, Saba Beigh, Saad Alghamdi, Nada Alsakhen, Elshiekh B Khidir, Hayaa M Alhuthali, Taqwa Hafiz Elamin Karamalla, Amgad M Rabie
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Scientific reports 13 (1) (2023)
Nermin A Osman, Mohammed Moustapha Anwar, Bivek Singh, Girish K Gupta, Amgad M Rabie
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM). The Journal of the Egyptian Public Health Association 98 (1) (2023)
Wafa A Eltayb, Mohnad Abdalla, Amgad M Rabie
Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir "S-217622": A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species. ACS omega 8 (6) (2023)
Amgad M Rabie, Wafa Ali Eltayb
Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study. Molecular biotechnology (2023)
Yasser Hussein Eissa Mohammed, Israa M Shamkh, Nahed S Alharthi, Mohammed A Shanawaz, Hind A Alzahrani, Basit Jabbar, Saba Beigh, Saad Alghamdi, Nada Alsakhen, Elshiekh B Khidir, Hayaa M Alhuthali, Taqwa Hafiz Elamin Karamalla, Amgad M Rabie
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Scientific reports 13 (1) (2023)
Wafa A Eltayb, Mohnad Abdalla, Amgad M Rabie
Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir "S-217622": A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species. ACS omega 8 (6) (2023)
Amgad M Rabie
Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease. ACS omega 7 (25) (2022)
Amgad M Rabie, Mohnad Abdalla
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents (2022)
Amgad M Rabie, Mohnad Abdalla
A Series of Adenosine Analogs as the First Efficacious Anti-SARS-CoV-2 Drugs against the B.1.1.529.4 Lineage: A Preclinical Repurposing Research Study. ChemistrySelect 7 (46) (2022)
Amgad M Rabie, Mohnad Abdalla
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 32 (2) (2022)
Amgad M Rabie
Retraction Note: CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy. Molecular diversity (2022)
Amgad M Rabie, Mohnad Abdalla
A Series of Adenosine Analogs as the First Efficacious Anti-SARS-CoV-2 Drugs against the B.1.1.529.4 Lineage: A Preclinical Repurposing Research Study. ChemistrySelect 7 (46) (2022)
Amgad M Rabie, Mohnad Abdalla
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents (2022)
Amgad M Rabie, Mohnad Abdalla
A Series of Adenosine Analogs as the First Efficacious Anti-SARS-CoV-2 Drugs against the B.1.1.529.4 Lineage: A Preclinical Repurposing Research Study. ChemistrySelect 7 (46) (2022)
Amgad M Rabie, Mohnad Abdalla
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 32 (2) (2022)
Amgad M Rabie, Mohnad Abdalla
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents (2022)
Amgad M Rabie
Retraction Note to: Discovery of ( E )- N -(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug. Chemicke zvesti 76 (9) (2022)
Amgad M Rabie
Potent Inhibitory Activities of the Adenosine Analogue Cordycepin on SARS-CoV-2 Replication. ACS omega 7 (3) (2022)
Amgad M Rabie, Mohnad Abdalla
Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies. ACS bio & med chem Au 2 (6) (2022)
Amgad M Rabie
Discovery of (E)-N-(4-cyanobenzylidene)- 6-fluoro- 3-hydroxypyrazine-2 -carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug. Chemicke zvesti (2021)
Amgad M Rabie
CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy. Molecular diversity 25 (3) (2021)